LIMAX | RGAEX | LIMAX / RGAEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 22 years | - |
Gain YTD | 17.822 | 26.450 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 250 | 800% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 31.8M | 298B | 0% |
Annual Yield % from dividends | 0.00 | 0.44 | - |
Returns for 1 year | 29.82 | 27.88 | 107% |
Returns for 3 years | -32.58 | -4.57 | 713% |
Returns for 5 years | -15.30 | 52.97 | -29% |
Returns for 10 years | -51.97 | 69.83 | -74% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TEMIX | 23.86 | 0.01 | +0.04% |
Franklin Mutual International Value A | |||
USLUX | 21.14 | -0.09 | -0.42% |
US Global Investors Global Luxury Goods | |||
DCSYX | 63.99 | -0.41 | -0.64% |
Davis Balanced Fund Y | |||
DGAGX | 45.08 | -0.81 | -1.77% |
BNY Mellon Appreciation Investor | |||
THISX | 92.91 | -3.08 | -3.21% |
T. Rowe Price Health Sciences I |